ENTEROSGEL patients saw a significant improvement in their other IBS symptoms: bloating, urgency and stool frequency compared to placebo. 76% of all patients reported “adequate relief” of their IBS symptoms after they had all tried ENTEROSGEL during the open-label phase of the trial.